ICL Israel Chemicals Ltd (ICL) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
ICL Israel Chemicals Ltd stock (ICL) is currently trading at $5.16. ICL Israel Chemicals Ltd PE ratio is 27.39. ICL Israel Chemicals Ltd PS ratio (Price-to-Sales) is 0.89. Analyst consensus price target for ICL is $5.90. WallStSmart rates ICL as Underperform.
- ICL PE ratio analysis and historical PE chart
- ICL PS ratio (Price-to-Sales) history and trend
- ICL intrinsic value — DCF, Graham Number, EPV models
- ICL stock price prediction 2025 2026 2027 2028 2029 2030
- ICL fair value vs current price
- ICL insider transactions and insider buying
- Is ICL undervalued or overvalued?
- ICL Israel Chemicals Ltd financial analysis — revenue, earnings, cash flow
- ICL Piotroski F-Score and Altman Z-Score
- ICL analyst price target and Smart Rating
ICL Israel Chemicals
📊 No data available
Try selecting a different time range
ICL Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · ICL Israel Chemicals Ltd (ICL)
ICL trades 236% above its Graham fair value of $1.71, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
ICL Israel Chemicals Ltd (ICL) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around peg ratio and return on equity. Mixed signals suggest waiting for clearer direction before acting.
ICL Israel Chemicals Ltd (ICL) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading at 1.06x book value, attractively priced
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
ICL Israel Chemicals Ltd (ICL) Areas to Watch (7)
Very low returns on shareholder equity
Very expensive relative to growth, significant premium
Very thin margins with limited operational efficiency
Earnings barely growing at 1.70%
Very thin margins, barely profitable
Modest revenue growth at 6.20%
Moderate institutional interest at 38.48%
Supporting Valuation Data
ICL Israel Chemicals Ltd (ICL) Detailed Analysis Report
Overall Assessment
This company scores 45/100 in our Smart Analysis, earning a D+ grade. Out of 10 metrics analyzed, 3 register as strengths (avg 8.3/10) while 7 fall into concern territory (avg 2.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Market Cap. Valuation metrics including Price/Sales (0.89), Price/Book (1.06) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, PEG Ratio, Operating Margin. Some valuation metrics including PEG Ratio (9.44) suggest expensive pricing. Growth concerns include Revenue Growth at 6.20%, EPS Growth at 1.70%, which may limit upside. Profitability pressure is visible in Return on Equity at 4.58%, Operating Margin at 6.35%, Profit Margin at 3.16%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 4.58% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 6.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and PEG Ratio are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ICL Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ICL's Price-to-Sales ratio of 0.89x trades 24% below its historical average of 1.17x (22th percentile). The current valuation is 61% below its historical high of 2.31x set in Nov 2021, and 44% above its historical low of 0.62x in Oct 2023. Over the past 12 months, the PS ratio has compressed from ~1.1x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for ICL Israel Chemicals Ltd (ICL) · BASIC MATERIALS › AGRICULTURAL INPUTS
The Big Picture
ICL Israel Chemicals Ltd is a mature, profitable business with steady cash generation. Revenue reached 7.2B with 6% growth year-over-year. Profit margins are strong at 316.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 458.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 25M in free cash flow and 301M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Dividend sustainability with a current yield of 365.0%. Watch payout ratio and free cash flow coverage.
Debt management: total debt of 2.7B is significantly higher than cash (356M). Monitor refinancing risk.
Sector dynamics: monitor AGRICULTURAL INPUTS industry trends, competitive moves, and regulatory changes that could impact ICL Israel Chemicals Ltd.
Bottom Line
ICL Israel Chemicals Ltd is a well-established business delivering consistent profitability with 316.0% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:24:29 AM
About ICL Israel Chemicals Ltd(ICL)
NYSE
BASIC MATERIALS
AGRICULTURAL INPUTS
USA
ICL Group Ltd, is a company specialized in minerals and chemical products worldwide. The company is headquartered in Tel Aviv, Israel.